Literature DB >> 16338273

Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.

Tommy Andersson1, David A Flockhart, David B Goldstein, Shiew-Mei Huang, Deanna L Kroetz, Patrice M Milos, Mark J Ratain, Kenneth Thummel.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16338273     DOI： 10.1016/j.clpt.2005.08.013

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  17 in total

1.  Pharmacotherapy and pregnancy: Highlights from the first International Conference for Individualized Pharmacotherapy in Pregnancy.

Authors:  David M Haas; Jamie L Renbarger; Scott Denne; Mahmoud S Ahmed; Thomas Easterling; Karen Feibus; Eric M Meslin; Gideon Koren; Anne Zajicek; Wayne R Snodgrass; David A Flockhart
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

Review 2.  Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.

Authors:  Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.

Authors:  Nicole G Hunfeld; Ron A Mathot; Daan J Touw; Ron H van Schaik; Paul G Mulder; Paul F Franck; Ernst J Kuipers; William P Geus
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

4.  Circulating microparticles and endogenous estrogen in newly menopausal women.

Authors:  M Jayachandran; R D Litwiller; W G Owen; V M Miller
Journal:  Climacteric       Date:  2009-04       Impact factor: 3.005

5.  Pharmacogenomics, evidence, and the role of payers.

Authors:  P A Deverka
Journal:  Public Health Genomics       Date:  2009-02-10       Impact factor: 2.000

6.  Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic.

Authors:  David M Haas; Sara K Quinney; Jayanti M Clay; Jamie L Renbarger; Mary F Hebert; Shannon Clark; Jason G Umans; Steve N Caritis
Journal:  Am J Perinatol       Date:  2012-08-08       Impact factor: 1.862

7.  Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.

Authors:  David M Haas; Mary F Hebert; Offie P Soldin; David A Flockhart; Parvaz Madadi; James J Nocon; Christina D Chambers; Gary D Hankins; Shannon Clark; Katherine L Wisner; Lang Li; Jamie L Renbarger; Lee A Learman
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

8.  Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients.

Authors:  Mateusz Kurzawski; Barbara Gawrońska-Szklarz; Joanna Wrześniewska; Andrzej Siuda; Teresa Starzyńska; Marek Droździk
Journal:  Eur J Clin Pharmacol       Date:  2006-08-16       Impact factor: 2.953

Review 9.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

10.  Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women.

Authors:  Muthuvel Jayachandran; Robert D Litwiller; Whyte G Owen; John A Heit; Thomas Behrenbeck; Sharon L Mulvagh; Philip A Araoz; Matthew J Budoff; S Mitchell Harman; Virginia M Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-11       Impact factor: 4.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.